Brief: Australian Clinical Labs Announces Sale Of Crescent Capital Shareholding
Sept 12 (Reuters) - Australian Clinical Labs Ltd
ACL.AX :
* SALE OF CRESCENT CAPITAL SHAREHOLDING
* CRESCENT CAPITAL HAS CONFIRMED TO AUSTRALIAN CLINICAL LABS
THAT
IT HAS SOLD ITS 30.12% SHAREHOLDING IN A BLOCK TRADE
* CRESCENT CAPITAL NO LONGER HOLDS SHARES IN ACL VIA ITS
VARIOUS
INVESTMENT VEHICLES
Further company coverage: ACL.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million